The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Also, the monoclonal antibody combo resolved symptoms and reduced viral load faster than a placebo.
People in rural areas are currently twice as likely to die from COVID-19 as their urban peers, new data show.
Critically ill COVID-19 patients who received extracorporeal membrane oxygenation (ECMO) at the end of 2020 had a higher mortality rate than those who received it in the first half of the year, according to a study published yesterday in The Lancet.
In a Chinese study, 45% had at least 1 persistent symptom after a year, and 16% had at least 3 symptoms.
Also, CDC data show similar side effects after a third Pfizer vaccine dose as seen after the second dose.
Cases and deaths continue to drop globally, but infections continue at very high levels.
Seven COVID-19 symptoms can maximize detection of COVID-19 in the community, according to a large study published in PLOS Medicine yesterday that looked at data from England's REal-time Assessment of Community Transmission-1 (REACT-1) study.
Pfizer and BioNTech say an application for emergency use authorization in kids 5 to 11 years old will likely follow.
Of the women, 8.14% used cannabis in spring 2020, compared with 6.75% before the pandemic.
Vaccine effectiveness (VE) for the two-dose Pfizer/BioNTech COVID-19 vaccine was up to 91.5% in Israeli teens 12 to 15 years old during the Delta (B1617.2) variant outbreak, according to a study published yesterday in Emerging Infectious Diseases.
